US Stock MarketDetailed Quotes

INM InMed Pharmaceuticals

Watchlist
  • 0.3977
  • -0.0138-3.35%
Close Aug 23 16:00 ET
  • 0.3840
  • -0.0137-3.44%
Post 20:02 ET
3.55MMarket Cap-736P/E (TTM)

InMed Pharmaceuticals Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(Q2)Dec 31, 2023
(Q1)Sep 30, 2023
(FY)Jun 30, 2023
(Q4)Jun 30, 2023
(Q3)Mar 31, 2023
(Q2)Dec 31, 2022
(Q1)Sep 30, 2022
(FY)Jun 30, 2022
(Q4)Jun 30, 2022
Total revenue
13.41%1.17M
163.99%1.24M
181.14%901.86K
279.61%4.14M
348.96%2.31M
233.97%1.03M
77.22%469.78K
320.79K
1.09M
514.76K
Operating revenue
13.41%1.17M
163.99%1.24M
181.14%901.86K
279.61%4.14M
348.96%2.31M
233.97%1.03M
77.22%469.78K
--320.79K
--1.09M
--514.76K
Cost of revenue
4.96%883.14K
170.53%916.06K
8.48%880.62K
400.56%2.73M
179.46%740.69K
560.93%841.41K
120.55%338.62K
811.81K
545.89K
265.04K
Gross profit
50.36%289.46K
147.13%324.14K
104.33%21.24K
158.13%1.4M
528.87%1.57M
5.61%192.51K
17.58%131.16K
-491.02K
543.55K
249.71K
Operating expense
-10.94%2.09M
-14.22%2.03M
-11.46%2.65M
-31.76%9.78M
-36.71%2.09M
-37.08%2.34M
-46.53%2.37M
3.30%2.99M
44.24%14.34M
-0.28%3.3M
Selling and administrative expenses
-2.73%1.37M
-6.89%1.36M
-16.77%1.3M
-14.85%5.85M
-19.11%1.41M
-26.23%1.41M
-20.25%1.46M
13.67%1.56M
53.30%6.87M
11.60%1.74M
-General and administrative expense
-2.73%1.37M
-6.89%1.36M
-16.77%1.3M
-14.85%5.85M
-19.11%1.41M
-26.23%1.41M
-20.25%1.46M
13.67%1.56M
53.30%6.87M
11.60%1.74M
Research and development costs
-25.22%656.76K
-28.37%609.79K
-6.28%1.29M
-48.75%3.73M
-58.44%623.74K
-49.91%878.3K
-66.44%851.36K
-7.55%1.38M
36.43%7.28M
-12.56%1.5M
Depreciation amortization depletion
8.05%54.77K
12.61%55.23K
11.79%54.83K
8.94%202.25K
-0.97%53.46K
-4.97%50.69K
-1.50%49.05K
71.91%49.05K
53.61%185.66K
88.45%53.99K
-Depreciation and amortization
8.05%54.77K
12.61%55.23K
11.79%54.83K
8.94%202.25K
-0.97%53.46K
-4.97%50.69K
-1.50%49.05K
71.91%49.05K
53.61%185.66K
88.45%53.99K
Operating profit
16.43%-1.8M
23.69%-1.7M
24.57%-2.62M
39.25%-8.38M
83.06%-516.26K
39.28%-2.15M
48.19%-2.23M
-20.28%-3.48M
-38.77%-13.79M
7.83%-3.05M
Net non-operating interest income expense
-21.89%121.46K
44.01%166.76K
87.42%136.04K
412.48%492.44K
340.81%148.56K
402.19%155.5K
340.68%115.8K
1,310.00%72.59K
127.91%96.09K
598.47%33.7K
Non-operating interest income
-21.89%121.46K
44.01%166.76K
87.42%136.04K
412.48%492.44K
340.81%148.56K
402.19%155.5K
340.68%115.8K
1,310.00%72.59K
499.93%96.09K
598.47%33.7K
Other net income (expense)
-1,662.02%-48.16K
195.97%59.9K
49.94%-48.46K
99.02%-48.18K
100.64%31.11K
-108.28%-2.73K
573.00%20.24K
-15.07%-96.79K
-6,267.03%-4.9M
-11,467.04%-4.86M
Gain on sale of security
-1,662.02%-48.16K
195.97%59.9K
49.94%-48.46K
96.64%-48.18K
102.25%31.11K
-108.28%-2.73K
573.00%20.24K
-15.07%-96.79K
-1,900.47%-1.43M
-3,338.89%-1.38M
Special income (charges)
----
----
----
--0
----
----
----
----
---3.47M
----
-Less:Impairment of capital assets
----
----
----
--0
----
----
----
----
--3.47M
----
Income before tax
13.70%-1.72M
29.55%-1.48M
27.59%-2.54M
57.34%-7.93M
95.72%-336.59K
42.56%-2M
51.01%-2.1M
-17.90%-3.5M
-82.30%-18.6M
-141.50%-7.87M
Income tax
0
0
0
13.1K
1.8K
1.5K
3K
6.8K
0
0
Net income
13.77%-1.72M
29.65%-1.48M
27.73%-2.54M
57.27%-7.95M
95.70%-338.39K
42.52%-2M
50.94%-2.1M
-18.12%-3.51M
-82.30%-18.6M
-141.50%-7.87M
Net income continuous Operations
13.77%-1.72M
29.65%-1.48M
27.73%-2.54M
57.27%-7.95M
95.70%-338.39K
42.52%-2M
50.94%-2.1M
-18.12%-3.51M
-82.30%-18.6M
-141.50%-7.87M
Minority interest income
Net income attributable to the parent company
13.77%-1.72M
29.65%-1.48M
27.73%-2.54M
57.27%-7.95M
95.70%-338.39K
42.52%-2M
50.94%-2.1M
-18.12%-3.51M
-82.30%-18.6M
-141.50%-7.87M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
13.77%-1.72M
29.65%-1.48M
27.73%-2.54M
57.27%-7.95M
95.70%-338.39K
42.52%-2M
50.94%-2.1M
-18.12%-3.51M
-82.30%-18.6M
-141.50%-7.87M
Basic earnings per share
70.00%-0.18
79.12%-0.19
81.28%-0.76
-144.95%-3.25
102.31%0.28
90.23%-0.6
88.23%-0.91
34.20%-4.06
96.50%-1.3268
-18.47%-12.0953
Diluted earnings per share
70.00%-0.18
79.12%-0.19
81.28%-0.76
-144.95%-3.25
102.31%0.28
90.23%-0.6
88.23%-0.91
34.20%-4.06
96.50%-1.3268
-18.47%-12.0953
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Mar 31, 2024(Q2)Dec 31, 2023(Q1)Sep 30, 2023(FY)Jun 30, 2023(Q4)Jun 30, 2023(Q3)Mar 31, 2023(Q2)Dec 31, 2022(Q1)Sep 30, 2022(FY)Jun 30, 2022(Q4)Jun 30, 2022
Total revenue 13.41%1.17M163.99%1.24M181.14%901.86K279.61%4.14M348.96%2.31M233.97%1.03M77.22%469.78K320.79K1.09M514.76K
Operating revenue 13.41%1.17M163.99%1.24M181.14%901.86K279.61%4.14M348.96%2.31M233.97%1.03M77.22%469.78K--320.79K--1.09M--514.76K
Cost of revenue 4.96%883.14K170.53%916.06K8.48%880.62K400.56%2.73M179.46%740.69K560.93%841.41K120.55%338.62K811.81K545.89K265.04K
Gross profit 50.36%289.46K147.13%324.14K104.33%21.24K158.13%1.4M528.87%1.57M5.61%192.51K17.58%131.16K-491.02K543.55K249.71K
Operating expense -10.94%2.09M-14.22%2.03M-11.46%2.65M-31.76%9.78M-36.71%2.09M-37.08%2.34M-46.53%2.37M3.30%2.99M44.24%14.34M-0.28%3.3M
Selling and administrative expenses -2.73%1.37M-6.89%1.36M-16.77%1.3M-14.85%5.85M-19.11%1.41M-26.23%1.41M-20.25%1.46M13.67%1.56M53.30%6.87M11.60%1.74M
-General and administrative expense -2.73%1.37M-6.89%1.36M-16.77%1.3M-14.85%5.85M-19.11%1.41M-26.23%1.41M-20.25%1.46M13.67%1.56M53.30%6.87M11.60%1.74M
Research and development costs -25.22%656.76K-28.37%609.79K-6.28%1.29M-48.75%3.73M-58.44%623.74K-49.91%878.3K-66.44%851.36K-7.55%1.38M36.43%7.28M-12.56%1.5M
Depreciation amortization depletion 8.05%54.77K12.61%55.23K11.79%54.83K8.94%202.25K-0.97%53.46K-4.97%50.69K-1.50%49.05K71.91%49.05K53.61%185.66K88.45%53.99K
-Depreciation and amortization 8.05%54.77K12.61%55.23K11.79%54.83K8.94%202.25K-0.97%53.46K-4.97%50.69K-1.50%49.05K71.91%49.05K53.61%185.66K88.45%53.99K
Operating profit 16.43%-1.8M23.69%-1.7M24.57%-2.62M39.25%-8.38M83.06%-516.26K39.28%-2.15M48.19%-2.23M-20.28%-3.48M-38.77%-13.79M7.83%-3.05M
Net non-operating interest income expense -21.89%121.46K44.01%166.76K87.42%136.04K412.48%492.44K340.81%148.56K402.19%155.5K340.68%115.8K1,310.00%72.59K127.91%96.09K598.47%33.7K
Non-operating interest income -21.89%121.46K44.01%166.76K87.42%136.04K412.48%492.44K340.81%148.56K402.19%155.5K340.68%115.8K1,310.00%72.59K499.93%96.09K598.47%33.7K
Other net income (expense) -1,662.02%-48.16K195.97%59.9K49.94%-48.46K99.02%-48.18K100.64%31.11K-108.28%-2.73K573.00%20.24K-15.07%-96.79K-6,267.03%-4.9M-11,467.04%-4.86M
Gain on sale of security -1,662.02%-48.16K195.97%59.9K49.94%-48.46K96.64%-48.18K102.25%31.11K-108.28%-2.73K573.00%20.24K-15.07%-96.79K-1,900.47%-1.43M-3,338.89%-1.38M
Special income (charges) --------------0-------------------3.47M----
-Less:Impairment of capital assets --------------0------------------3.47M----
Income before tax 13.70%-1.72M29.55%-1.48M27.59%-2.54M57.34%-7.93M95.72%-336.59K42.56%-2M51.01%-2.1M-17.90%-3.5M-82.30%-18.6M-141.50%-7.87M
Income tax 00013.1K1.8K1.5K3K6.8K00
Net income 13.77%-1.72M29.65%-1.48M27.73%-2.54M57.27%-7.95M95.70%-338.39K42.52%-2M50.94%-2.1M-18.12%-3.51M-82.30%-18.6M-141.50%-7.87M
Net income continuous Operations 13.77%-1.72M29.65%-1.48M27.73%-2.54M57.27%-7.95M95.70%-338.39K42.52%-2M50.94%-2.1M-18.12%-3.51M-82.30%-18.6M-141.50%-7.87M
Minority interest income
Net income attributable to the parent company 13.77%-1.72M29.65%-1.48M27.73%-2.54M57.27%-7.95M95.70%-338.39K42.52%-2M50.94%-2.1M-18.12%-3.51M-82.30%-18.6M-141.50%-7.87M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 13.77%-1.72M29.65%-1.48M27.73%-2.54M57.27%-7.95M95.70%-338.39K42.52%-2M50.94%-2.1M-18.12%-3.51M-82.30%-18.6M-141.50%-7.87M
Basic earnings per share 70.00%-0.1879.12%-0.1981.28%-0.76-144.95%-3.25102.31%0.2890.23%-0.688.23%-0.9134.20%-4.0696.50%-1.3268-18.47%-12.0953
Diluted earnings per share 70.00%-0.1879.12%-0.1981.28%-0.76-144.95%-3.25102.31%0.2890.23%-0.688.23%-0.9134.20%-4.0696.50%-1.3268-18.47%-12.0953
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg